Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Latest Information Update: 28 Nov 2013
At a glance
- Drugs Anamorelin (Primary)
- Indications Anorexia; Cachexia
- Focus Therapeutic Use
- Sponsors Helsinn Therapeutics; Sapphire Therapeutics
- 28 Nov 2013 New trial record
- 11 Nov 2013 Data have been presented at the 2013 European Cancer Congress (Abstract number: 1316), according to a Helsinn media release.